Correlation Between Exscientia and Recursion Pharmaceuticals

Can any of the company-specific risk be diversified away by investing in both Exscientia and Recursion Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Exscientia and Recursion Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Exscientia Ltd ADR and Recursion Pharmaceuticals, you can compare the effects of market volatilities on Exscientia and Recursion Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Exscientia with a short position of Recursion Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Exscientia and Recursion Pharmaceuticals.

Diversification Opportunities for Exscientia and Recursion Pharmaceuticals

0.03

Correlation Coefficient

Exscientia  Recursion Pharmaceuticals

Significant diversification

The 3 months correlation between Exscientia and Recursion is 0.03. Overlapping area represents the amount of risk that can be diversified away by holding Exscientia Ltd ADR and Recursion Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Recursion Pharmaceuticals and Exscientia is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Exscientia Ltd ADR are associated (or correlated) with Recursion Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Recursion Pharmaceuticals has no effect on the direction of Exscientia i.e., Exscientia and Recursion Pharmaceuticals go up and down completely randomly.

Pair Corralation between Exscientia and Recursion Pharmaceuticals

Given the investment horizon of 90 days Exscientia is expected to generate 4.56 times less return on investment than Recursion Pharmaceuticals. But when comparing it to its historical volatility, Exscientia Ltd ADR is 1.13 times less risky than Recursion Pharmaceuticals. It trades about 0.01 of its potential returns per unit of risk. Recursion Pharmaceuticals is currently generating about 0.04 of returns per unit of risk over similar time horizon. If you would invest  607.00  in Recursion Pharmaceuticals on August 31, 2024 and sell it today you would earn a total of  31.00  from holding Recursion Pharmaceuticals or generate 5.11% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Insignificant
Accuracy	92.06%
Values	Daily Returns

Exscientia Ltd ADR  vs.  Recursion Pharmaceuticals

Exscientia ADR

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Exscientia Ltd ADR has generated negative risk-adjusted returns adding no value to investors with long positions. Despite fairly strong basic indicators, Exscientia is not utilizing all of its potentials. The newest stock price confusion, may contribute to short-horizon losses for the traders.

Recursion Pharmaceuticals

Risk-Adjusted Performance

3 of 100

Insignificant

Compared to the overall equity markets, risk-adjusted returns on investments in Recursion Pharmaceuticals are ranked lower than 3 (%) of all global equities and portfolios over the last 90 days. In spite of fairly inconsistent basic indicators, Recursion Pharmaceuticals may actually be approaching a critical reversion point that can send shares even higher in December 2024.

Pair Trading with Exscientia and Recursion Pharmaceuticals

The main advantage of trading using opposite Exscientia and Recursion Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Exscientia position performs unexpectedly, Recursion Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Recursion Pharmaceuticals will offset losses from the drop in Recursion Pharmaceuticals' long position.

The idea behind Exscientia Ltd ADR and Recursion Pharmaceuticals pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Rebalancing module to analyze risk-adjusted returns against different time horizons to find asset-allocation targets.